Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments.
Dishman Carbogen Amcis Limited (DCAL) is listed on the NSE in the Healthcare sector, Biotechnology industry. The DCAL share price is ₹156.64 (-0.56% today), with a market capitalisation of ₹25B and a price-to-earnings (P/E) ratio of 152.1. MarketRipple tracks the DCAL investment thesis, the ripple-chain impact of market events on Dishman Carbogen Amcis Limited, and the Healthcare sector outlook.
Open
₹155.20
High
₹157.50
Low
₹153.20
Prev. Close
₹157.52
52W High
₹274.30
52W Low
₹128.50
Day range
₹153.20–₹157.50
52-week range
₹128.50–₹274.30
Volume
87K
P/E
152.1
ROE
1.5%
D/E
0.46
Margin
0.6%
Dishman Carbogen Amcis Limited (NSE: DCAL) is currently trading at ₹156.64 (-0.56%).
Dishman Carbogen Amcis Limited's market capitalization is ₹25B.
Dishman Carbogen Amcis Limited's price-to-earnings (P/E) ratio is 152.1.
Dishman Carbogen Amcis Limited operates in the Healthcare sector (Biotechnology).